TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

26 hedge funds and large institutions have $34.2M invested in Theriva Biologics in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

0% less ownership

Funds ownership: 0% → 0% (-0%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$280K
2
+$178K
3
+$74K
4
M&T Bank
M&T Bank
New York
+$65K
5
PP
Paloma Partners
Connecticut
+$57K

Top Sellers

1
-$345K
2
-$180K
3
-$43K
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$41K
5
Bank of America
Bank of America
North Carolina
-$31.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$14K
27
$5K
28
$4K
29
$4K
30
$2K
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
1
2